Michael Petusky
Stock Analyst at Barrington Research
(2.26)
# 2,738
Out of 5,182 analysts
237
Total ratings
39.81%
Success rate
-2.41%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical | Maintains: Outperform | $17 | $12.72 | +33.65% | 7 | Apr 10, 2026 | |
| LFCR Lifecore Biomedical | Maintains: Outperform | $5.5 | $5.20 | +5.77% | 9 | Mar 27, 2026 | |
| BVS Bioventus | Maintains: Outperform | $13 → $14 | $9.91 | +41.27% | 2 | Mar 6, 2026 | |
| OPK OPKO Health | Maintains: Outperform | $2.25 → $1.5 | $1.17 | +28.21% | 16 | Mar 2, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $14 → $17 | $12.22 | +39.12% | 28 | Mar 2, 2026 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $16 → $17 | $15.30 | +11.11% | 22 | Feb 27, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $95 → $105 | $117.39 | -10.55% | 15 | Feb 26, 2026 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $106 → $109 | $70.54 | +54.52% | 26 | Feb 25, 2026 | |
| HSIC Henry Schein | Maintains: Outperform | $79 → $97 | $77.20 | +25.65% | 19 | Feb 25, 2026 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $103 | $77.13 | +33.54% | 27 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $94 | $60.48 | +55.42% | 36 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $42 | $27.90 | +50.54% | 19 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1 → $1.5 | $0.90 | +66.67% | 11 | Jan 6, 2026 |
Orthofix Medical
Apr 10, 2026
Maintains: Outperform
Price Target: $17
Current: $12.72
Upside: +33.65%
Lifecore Biomedical
Mar 27, 2026
Maintains: Outperform
Price Target: $5.5
Current: $5.20
Upside: +5.77%
Bioventus
Mar 6, 2026
Maintains: Outperform
Price Target: $13 → $14
Current: $9.91
Upside: +41.27%
OPKO Health
Mar 2, 2026
Maintains: Outperform
Price Target: $2.25 → $1.5
Current: $1.17
Upside: +28.21%
DENTSPLY SIRONA
Mar 2, 2026
Maintains: Outperform
Price Target: $14 → $17
Current: $12.22
Upside: +39.12%
Anika Therapeutics
Feb 27, 2026
Maintains: Outperform
Price Target: $16 → $17
Current: $15.30
Upside: +11.11%
LeMaitre Vascular
Feb 26, 2026
Maintains: Outperform
Price Target: $95 → $105
Current: $117.39
Upside: -10.55%
Merit Medical Systems
Feb 25, 2026
Maintains: Outperform
Price Target: $106 → $109
Current: $70.54
Upside: +54.52%
Henry Schein
Feb 25, 2026
Maintains: Outperform
Price Target: $79 → $97
Current: $77.20
Upside: +25.65%
U.S. Physical Therapy
Feb 20, 2026
Maintains: Outperform
Price Target: $103
Current: $77.13
Upside: +33.54%
Feb 6, 2026
Maintains: Outperform
Price Target: $93 → $94
Current: $60.48
Upside: +55.42%
Jan 16, 2026
Maintains: Outperform
Price Target: $38 → $42
Current: $27.90
Upside: +50.54%
Jan 6, 2026
Maintains: Outperform
Price Target: $1 → $1.5
Current: $0.90
Upside: +66.67%